Gram-positive bacteria do not produce endotoxins in the classical sense. Endotoxin refers specifically to lipopolysaccharide (LPS), a molecule embedded in the outer membrane of Gram-negative bacteria, and Gram-positive species simply lack the outer membrane where LPS resides.1PubMed. Endotoxins: lipopolysaccharides of gram-negative bacteria That said, the real story is more nuanced than a flat “no.” Gram-positive bacteria carry their own set of potent inflammatory molecules, some of which trigger immune responses strikingly similar to those caused by LPS, and a few historical findings have blurred the line further.
Why the Answer Starts With Cell Architecture
The reason endotoxin is absent from Gram-positive bacteria comes down to how their walls are built. Gram-negative bacteria have a thin inner layer of peptidoglycan surrounded by an outer membrane, and the outer leaflet of that membrane is made largely of LPS. Gram-positive bacteria have no outer membrane at all. Instead, they are wrapped in a much thicker peptidoglycan layer studded with different molecules, primarily teichoic acids and lipoteichoic acid (LTA).2PubMed Central. The bacterial cell envelope Because there is no outer membrane to house LPS, there is no endotoxin. It is a structural impossibility, not just a tendency.
This distinction matters because endotoxin is not something bacteria actively secrete like a poison. LPS sits in the membrane and gets released when the bacterium breaks apart or sheds fragments. The term “endotoxin” literally means “toxin from within,” coined over a century ago to distinguish it from exotoxins that bacteria deliberately export. Since the molecule itself is a fixed part of a structure Gram-positive bacteria never build, calling anything a Gram-positive endotoxin would be a contradiction in terms by the original definition.
The Gram-Positive Molecules That Act Like Endotoxin
Although Gram-positive bacteria do not carry LPS, they are perfectly capable of causing the same catastrophic immune reactions, including septic shock and organ failure. The molecules responsible are lipoteichoic acid and peptidoglycan, both of which are major components of the thick Gram-positive cell wall. LTA in particular has drawn attention because it shares so many pathological properties with endotoxin. It binds to the same receptor (CD14) on immune cells, activates the complement cascade, and triggers neutrophils and macrophages to release reactive oxygen species, inflammatory cytokines, and tissue-damaging enzymes.3PubMed. Role of lipoteichoic acid in infection and inflammation
In animal studies, LTA has induced arthritis, kidney inflammation, meningeal inflammation, and periodontal lesions, and has triggered cascades leading to septic shock and multiorgan failure.3PubMed. Role of lipoteichoic acid in infection and inflammation This is why some researchers have informally called LTA the “Gram-positive endotoxin,” even though strictly speaking it is a different molecule acting through a partially overlapping but distinct signaling pathway.
Peptidoglycan, the other major wall component, also provokes significant inflammation. When researchers administered LTA and peptidoglycan from Staphylococcus aureus into mouse lungs, both compounds induced acute inflammation with dose-dependent neutrophil influx.4American Journal of Respiratory and Critical Care Medicine. Differential Role of Interleukin-6 in Lung Inflammation Induced by Lipoteichoic Acid and Peptidoglycan from Staphylococcus aureus Gram-positive cell walls from eight different species all prompted human monocytes to produce TNF-alpha and interleukin-6, confirming that this is not a quirk of one species but a general property of Gram-positive wall architecture.5PubMed Central. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes
How the Immune System Tells Them Apart
Even though LPS and Gram-positive wall molecules both provoke fierce immune responses, your body recognizes them through different front doors. LPS is detected mainly by Toll-like receptor 4 (TLR4), while peptidoglycan and lipoteichoic acid are recognized primarily by Toll-like receptor 2 (TLR2). Experiments with mice that lacked one receptor or the other showed this clearly: TLR2-deficient macrophages barely responded to S. aureus peptidoglycan, while TLR4-deficient macrophages were unresponsive to LPS but handled peptidoglycan normally.6PubMed. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
The picture gets more interesting with LTA itself, which turns out to interact with both TLR2 and TLR4 in complex ways. One study found that LTA can actually suppress TLR4 signaling by forming an inactive complex with MD-2, the co-receptor that normally helps TLR4 respond to LPS.7The Journal of Immunology. Lipoteichoic Acid Inhibits Lipopolysaccharide-Induced TLR4 Signaling by Forming an Inactive TLR4/MD-2 Complex Dimer This implies that during a mixed infection involving both Gram-positive and Gram-negative bacteria, LTA might dampen the LPS response to some degree. And in TLR4-deficient mice, macrophages lost their response to Gram-positive LTA, suggesting LTA is not purely a TLR2 ligand.6PubMed. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components The signaling crosstalk between these receptors remains an active area of research.
Gram-Positive Shock Is Real, Just Driven Differently
For clinicians, the practical takeaway is that Gram-positive bacteria can absolutely cause septic shock, even without endotoxin. The clinical picture looks similar: fever, plummeting blood pressure, organ dysfunction. But the molecules driving it are different. As one review put it, Gram-positive microorganisms do not contain LPS, which is mainly responsible for initiating Gram-negative shock, yet the elevated release of inflammatory mediators and cytokines by host cells produces the same devastating clinical syndrome.8Trends in Microbiology. Gram-positive bacterial shock: a first round
There are meaningful differences in the cytokine profiles, though. When researchers compared whole Gram-positive and Gram-negative bacteria head to head for their effects on human monocytes, both types were equally good at inducing IL-1 beta. But Gram-positive bacteria generated roughly twice as much TNF-alpha, while Gram-negative bacteria produced at least twice as much IL-6 and IL-8.9PubMed. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes Interestingly, the strong TNF-alpha and IL-1 beta responses triggered by intact Gram-positive bacteria could not be replicated by purified peptidoglycan or LTA alone, suggesting the whole bacterial cell wall has emergent inflammatory properties that exceed what any single component does on its own.9PubMed. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes
Potency also differs. On a weight-for-weight basis, intact peptidoglycan is roughly a thousand times less active than LPS at triggering cytokine release, though it acts through the same CD14 receptor.10PubMed. Proinflammatory activity of cell-wall constituents from gram-positive bacteria That sounds reassuring until you remember that the thick Gram-positive wall contains enormous quantities of peptidoglycan, so what it lacks in per-molecule potency it can partly compensate for in sheer volume, especially during aggressive infections or antibiotic-induced bacterial die-off.
The Antibiotic Problem
When antibiotics kill bacteria, the cells burst open and release their wall components into the bloodstream or tissue. This event, called bacteriolysis, is relevant for both types of bacteria but creates distinct hazards. For Gram-negative infections, the worry has long been that beta-lactam antibiotics shatter bacteria and dump LPS, temporarily worsening the inflammatory response. The same principle applies to Gram-positive infections: killing Staphylococcus or Streptococcus bacteria with antibiotics frees LTA and peptidoglycan, both of which can act on macrophages individually or in synergy to provoke reactive oxygen species, inflammatory cytokines, and activation of the coagulation and complement cascades.11PubMed. The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae
This is why patients with severe Gram-positive infections sometimes worsen temporarily after starting antibiotics. The initial wave of bacterial killing floods the system with inflammatory debris, and since LTA and peptidoglycan together trigger overlapping cytokine cascades, the clinical result can look a lot like the endotoxin-mediated worsening seen in Gram-negative sepsis.
A Historical Controversy That Muddied the Waters
If you have encountered claims that certain Gram-positive bacteria “do” produce endotoxin, the source is likely a 1979 study on Listeria monocytogenes. Researchers extracted a substance from Listeria that was, by every test available at the time, chemically and biologically identical to classical Gram-negative LPS. It contained beta-hydroxymyristic acid (a fatty acid signature of LPS), was toxic and pyrogenic in rabbits, and triggered the Limulus lysate assay used to detect endotoxin.12PubMed Central. Isolation, characterization, and biological properties of an endotoxin-like material from the gram-positive organism Listeria monocytogenes The paper’s title openly called it “endotoxin-like material from the gram-positive organism.”
Later work cast serious doubt on that finding. A 1983 study reanalyzed L. monocytogenes and found that its cell wall products were typical of Gram-positive bacteria, containing lipoteichoic acid rather than LPS. The authors explicitly noted their results contradicted the earlier reports of LPS from Listeria.13PubMed Central. Lipoteichoic acid from Listeria monocytogenes The most likely explanation is contamination or co-purification of trace LPS from reagents or growth media, a problem that has haunted the entire field of Gram-positive wall research.
The Contamination Problem in Research
One of the most underappreciated issues in this field is that commercially available LTA preparations have often been contaminated with endotoxin. A study testing LTA products purified from S. aureus, Bacillus subtilis, and Streptococcus sanguis found that while these preparations readily stimulated mouse macrophages, the activity was dramatically inhibited by polymyxin B, a compound that specifically blocks LPS activity.14PubMed Central. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro In other words, a significant fraction of what researchers thought was LTA activity was actually endotoxin contamination doing the work.
This finding sent ripples through the field. Many earlier studies that had attributed strong inflammatory effects to LTA were potentially measuring endotoxin contamination instead. It raised the uncomfortable question of how much of the “Gram-positive endotoxin equivalent” narrative was built on flawed reagents. More recent research using highly purified LTA has confirmed that genuine LTA does trigger inflammation, but not always to the degree initially claimed using contaminated preparations. The lesson is a useful reminder that lab results can be shaped by impurities, and early findings in any area of microbiology deserve scrutiny as methods improve.
How This Affects Safety Testing for Drugs and Medical Devices
The distinction between true endotoxin and Gram-positive pyrogens has real consequences for anyone involved in pharmaceutical manufacturing. The standard test for detecting pyrogenic (fever-causing) contamination in injectable drugs and medical devices has long been the Limulus Amebocyte Lysate (LAL) test, which reacts specifically to LPS. The LAL test is excellent at catching Gram-negative contamination, but by design it is blind to LTA, peptidoglycan, and other non-endotoxin pyrogens.
This gap matters because a drug vial contaminated with Staphylococcus cell wall fragments could pass a LAL test with flying colors and still cause fever or worse in a patient. An alternative approach, the Monocyte Activation Test (MAT), uses human blood cells rather than horseshoe crab lysate and reliably detects non-endotoxin pyrogens including heat-killed S. aureus and LTA in addition to LPS.15PubMed Central. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens A review of the evidence concluded that the whole-blood MAT reliably detects these non-endotoxin pyrogens, strengthening the case for broader adoption.16ALTEX – Alternatives to Animal Experimentation. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test
The MAT also revealed something else worth knowing: when endotoxin and non-endotoxin pyrogens are both present, their effects are not simply additive. They can synergize, producing a potentiated cytokine release greater than either contaminant would trigger alone.15PubMed Central. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens This means real-world contamination, which often involves multiple bacterial species, may be more dangerous than lab studies using a single pure compound would predict.
On the depyrogenation side, low-pressure microwave plasma treatment has been shown to rapidly destroy the immune-stimulating capacity of LPS, LTA, and fungal zymosan on surfaces, doing the job in seconds to minutes.17PubMed. Removal of immune-stimulatory components from surfaces by plasma discharges Standard dry-heat depyrogenation used in pharmaceutical manufacturing was designed primarily with LPS in mind, so the availability of methods effective against Gram-positive contaminants is increasingly important.
Cross-Tolerance Between Gram-Positive and Gram-Negative Signals
An intriguing wrinkle in the relationship between these two classes of bacterial molecules is that exposure to one can alter the immune response to the other. Mice pretreated with Gram-positive peptidoglycan showed elevated TNF-alpha and IL-10 shortly after injection. But when those mice were later challenged with live S. aureus, they had a suppressed inflammatory cytokine response compared to untreated mice, along with better bacterial clearance.18PubMed Central. Pretreatment with the Gram-positive Bacterial Cell Wall Molecule Peptidoglycan Improves Bacterial Clearance and Decreases Inflammation and Mortality in Mice Challenged with Staphylococcus aureus More striking still, peptidoglycan pretreatment also induced cross-tolerance to LPS and improved survival against Pseudomonas aeruginosa, a Gram-negative pathogen, suggesting the innate immune system’s response to Gram-positive wall fragments can recalibrate its handling of endotoxin as well.19PubMed Central. Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa
This kind of cross-talk makes sense when you consider that many of the downstream signaling molecules activated by TLR2 and TLR4 overlap. The immune system appears to use the initial low-level exposure as a training event, fine-tuning how aggressively it responds to subsequent threats regardless of the bacterial type.
Why Your Gut Does Not Constantly Inflame
Your intestines harbor trillions of Gram-positive bacteria, many of them coated in LTA and peptidoglycan. If these molecules are so inflammatory, why doesn’t your gut wall live in a permanent state of immune activation? Part of the answer is that intestinal epithelial cells keep TLR2 expression extremely low and maintain high levels of a dampening protein called Tollip. This combination prevents chronic inflammatory cytokine secretion in response to commensal Gram-positive bacteria in the gut.20PubMed. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut
Some beneficial bacteria may go even further. Research on Lactobacillus acidophilus engineered to lack LTA entirely showed that the LTA-deficient strain did not just stop provoking inflammation: it actively reduced it. Compared to the normal strain, the LTA-negative version suppressed pro-inflammatory IL-12 and TNF-alpha, boosted anti-inflammatory IL-10, and significantly reduced the severity of experimentally induced colitis in mice.21PubMed Central. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid The implication is that LTA from commensal bacteria is not inert; it contributes a low-grade pro-inflammatory signal that the healthy gut normally tolerates, but that might tip the balance in people with inflammatory bowel conditions. Removing that signal shifted the immune response toward active anti-inflammatory regulation.
Beyond Classical Gram-Positive and Gram-Negative Categories
The Gram stain divides bacteria into two camps, but biology does not always respect neat categories. Mycobacteria, including Mycobacterium tuberculosis, have unusual cell walls that stain poorly with the Gram method. They lack LPS but carry lipoarabinomannan (LAM), a glycolipid that behaves like yet another endotoxin analog. LAM triggers neutrophil influx and stimulates production of TNF-alpha, IL-1, and chemokines when administered to mouse lungs, acting as a potent stimulator of innate immunity.22PubMed. Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1 LAM adds to the growing picture that many different bacterial lineages have evolved surface-anchored lipid-containing molecules capable of triggering the same alarm pathways that LPS does, even when the molecule itself is chemically unrelated to endotoxin.
What unites all of these molecules, whether LPS, LTA, peptidoglycan, or LAM, is not their structure but their function: they are conserved microbial patterns recognized by the innate immune system. The immune system does not care much about Gram stain categories. It cares about detecting molecular patterns that signal “bacterium present” and mounting an appropriate defense. Endotoxin happens to be the most potent and best-studied trigger, but it is one member of a larger family of microbial alarm signals that Gram-positive and other non-Gram-negative organisms deploy just as effectively in the context of real infections.